UBS analyst upgrades Agree Realty Corp. (ADC) to Buy, citing increased acquisitions and growth in adjusted funds from ...

UBS cut Goldman Sachs (GS) to Neutral from Buy as the Wall Street firm's business model relies heavily on Global Banking & ...

Authorities entered impeached President Yoon Suk Yeol's compound, evading a crowd of protesters outside, but were confronted ...

UBS Group AG shares rose the most in two months as analysts at BNP Paribas Exane recommended buying on expectations the Swiss ...

Chinese stock investors should “stay on the defensive side” as consumption remains weak and volatility is expected to rise ...

Fintel reports that on January 6, 2025, UBS downgraded their outlook for Goldman Sachs Group, Inc. - Preferred Security (NYSE ...

New York’s Bull Riding Team Set to Bring the Excitement of America’s Original Extreme Sport to a New Venue in September 2025 ...

UBS upgraded LPL Financial (LPLA) to Buy from Neutral with a price target of $390, up from $280. The firm expects an acceleration of client ...

Adobe could lose ground as rivals like OpenAI establish themselves in the market for creative artificial intelligence, UBS ...

UBS downgraded Goldman Sachs (GS) to Neutral from Buy with a price target of $610, up from $600. The firm says the current valuation prices in ...

State-driven curbs on new facilities and production cuts by the biggest players will help rectify imbalance, analyst says.

BOSTON, January 06, 2025 -- ( BUSINESS WIRE )-- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), is pleased to announce that it has appointed UBS as its UK Corporate Broker ...